Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Crane

Showing results (811-820 of 813) with videos related to

Pageof 82
Sort By:
You have reached the last page of results.This site can display upto 813 results.
The New England Journal of Medicine|April 3, 2009
Effect of early versus deferred antiretroviral therapy for HIV on survivalMari M Kitahata, Stephen J Gange, Alison G Abraham, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 25, 2014
Long-term mortality in HIV-positive individuals virally suppressed for >3 years with incomplete CD4 recoveryFrederik N Engsig, Robert Zangerle, Olga Katsarou, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 31, 2016
Mortality According to CD4 Count at Start of Combination Antiretroviral Therapy Among HIV-infected Patients Followed for up to 15 Years After Start of Treatment: Collaborative Cohort StudyMargaret T May, Jorg-Janne Vehreschild, Adam Trickey, et al.
Pageof 82

Showing results (811-820 of 813) with videos related to

Sort By:
Pageof 82
You have reached the last page of results.This site can display upto 813 results.
The New England Journal of Medicine|April 3, 2009
Effect of early versus deferred antiretroviral therapy for HIV on survivalMari M Kitahata, Stephen J Gange, Alison G Abraham, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 25, 2014
Long-term mortality in HIV-positive individuals virally suppressed for >3 years with incomplete CD4 recoveryFrederik N Engsig, Robert Zangerle, Olga Katsarou, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 31, 2016
Mortality According to CD4 Count at Start of Combination Antiretroviral Therapy Among HIV-infected Patients Followed for up to 15 Years After Start of Treatment: Collaborative Cohort StudyMargaret T May, Jorg-Janne Vehreschild, Adam Trickey, et al.
Pageof 82